• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Identification of alpha-fetoprotein silencer and analysis of its regulatory mechanisms

Research Project

Project/Area Number 09670558
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionNagasaki University

Principal Investigator

NAKATA Keisuke  Nagasaki University, School of Medicine, Assistant Professor, 医学部, 助教授 (40217740)

Co-Investigator(Kenkyū-buntansha) NAKAO Kazuhiko  Nagasaki University, Health Research Center, Lecturer, 保健管理センター, 講師 (00264218)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 1998: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1997: ¥2,100,000 (Direct Cost: ¥2,100,000)
Keywordsalpha-Fetoprotein / Albumin / Silencer / HMGI-C / Rb gene / Ras gene / アルファフェトプロテイン / サイレンサー活性 / 肝癌
Research Abstract

The a-fetoprotein (AEP) silencer activity is relevant to repression of AFP expression after birth. Moreover, down-regulation of the silencer activity would lead to re-expression of the AFP gene in the hepatocarcinogenetic process. In the present study, the AFP silecer interacted with its enhancer, resulting in the inhibition of the enhancer activity. Furthermore, repression of the AFP enhancer activity depressed both the AFP and albumin gene expression. When retinoblastoma (Rb) gene or ras gene were transduced in HuH-7 human hepatoma cells, transduction of Rb gene up-regulated expression of the hepatocyte nuclear factor-1 (HNF-1) gene, a liver-specific transcriptional factor, which stimulated both the AFP and albumin gene transcription through activation of their promoters. Transduction of ras gene induced the suppression of the AFP enhancer activity and repressed the AFP gene transcription. In addition, the Rb gene transduction in HuH-7 cells not only stimulated HNF-1 expression but also promoted contact inhibition of cell growth. Thus the Rb gene was considered to function as a differeatiation inducer, although it did not directly induce the AFP silencer activity.
HMGI-C is a key factor involved in DNA loop formation and expressed highly in fetal organs or certain malignant cells. Expression of HMGI-C was analyzed in human hepatoma cell lines by means of RT-PCR.Its expression was apparenty higher in AFP-producing cells than nonproclucing cells. This would suggest the association of HMGI-C expression with the AFP silencer activity in human hepatoma cells.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (23 results)

All Other

All Publications (23 results)

  • [Publications] Satoshi Awazu: "Stable transfection of retinoblastoma gene gromotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcripiton in human hepatoma cells" Biochemical and Biophysical Research Communications. 252・1. 269-273 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hiroki Ishikawa: "Differential regulation of albumin gene expression by heparin-binding epidermal growth factor-like growth factor in α-fetoprotein (AFP)-producing and AFP-nonproducing human hepatoma cells" Tumor Biology. in press. (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hiroyuki Mazume: "Effect of simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on α-fetoprotein gene expression through interaction with the ras-mediated pathway" Journal of Hepatology. in press. (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Toshihito Ueki: "Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athmic mice" International Journal of Molecular Medicine. 1・4. 671-675 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Fumihiro Mawatari: "Retrovirus-mediated gene therapy for hepatocellular cacrinoma: Selective and enhanced suicide gene expression regulated by human α-fetoprotein enhancer directly linked to its promoter" Cancer Gene therapy. 5・5. 301-306 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hiroki Ishikawa: "Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma" Gene therapy. in press. (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Daisaku Hida: "Suppression of albumin and α-fetoprotein gene expression by butyrolactone I, a selective inhibitor of cdk family, in HuH-7 human hepatoma cells" Anticancer Research. 18・6A. 4317-4322 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Satoshi Awazu, Keisuke Nakata, Daisuke Hida, Tomoko Sakamoto, Kimiko Nagata, Nobuko Ishii, Takashi Kanematsu: "Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear facttor-1-mediated transcription in human hepatoma cells." Biochemical and Biophysical Research Communications. 252 (1). 269-273 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hiroki Ishikawa, Keisuke Nakata, Shotaro Tsuruta, Kazuhiko Nakao, Yuji Kato, Taiki Tamaoki, Katsumi Eguchi: "Differential regulation of albumin gene expression by heparin-binding epidermal growth factor-like growth factor in alpha-fetoprotein (AFP)-producing and AFP-nonproducing human hepatoma cells." Tumor Biology. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hiroyuki Mazume, Keisuke Nakata, Daisuke Hida, Keisuke Hamasaki, Shotaro Tsuruta, Kazuhiko Nakao, Yuji Kato, Katsumi Eguchi: "Effect of simvastatin, a 3-hydroxy-3-methylgutaryl coenzyme A reductase inhibitor, on alpha-fetoprotein gene expression through interaction with the ras-mediated pathway." Journal of Hepatology. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Toshihito Ueki, Keisuke Nakata, Fumihiro Mawatari, Shotaro Tsuruta, Akio Ido, Hiroyuki Ishikawa, Kazuhiko Nakao, Yuji Kato, Nobuko Ishii, Katsumi Eguchi: "Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice." International Journal of Molecular Medicine. 1(4). 671-675 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Fumihiro Mawatari, Shotaro Tsuruta, Akio Ido, Toshihito Ueki, Kazuhiko Nakao, Yuji Kato, Taiki Tamaoki, Nobuko Ishii, Keisuke Nakata: "Retrovirus-mediated gene therapy for hepatocellular cacrinoma : Selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter." Cancer Gene Therapy. 5 (5). 301-306 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hiroki Ishikawa, Keisuke Nakata, Fumihiro Mawatari, Toshihito Ueki, Shotaro Tsuruta, Akio Ido, Kazuhiko Nakao, Yuji Kato, Nobuko Ishii, Katsumi Eguchi: "Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma." Gene Therapy. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Daisaku Hida, Keisuke Nakata, Yuka Shima, Kiyoshi Migita, Keisuke Nakao, Yuji Kato, Nobuko Ishii, Katsumi Eguchi: "Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of cdk family, in HuH-7 human hepatoma cells." Anticancer Research. 18 (6A). 4317-4322 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Satoshi Awazu: "Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcripiton in human hepatoma cells" Biochemical and Biophysical Research Communications. 252・1. 269-273 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hiroki Ishikawa: "Differential regulation of albumin gene expression by heparin-binding epidermal growth factor-like growth factor in α-fetoprotein(AFP)-producing and AFP-nonproducing human hepatoma cells" Tumor Biology. (in press). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hiroyuki Mazume: "Effect of simvastatin,a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor,on α-fetoprotein gene expression through interaction with the ras-mediated pathway" Journal of Hepatoloy. (in press). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Toshihito Ueki: "Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice" International Journal of Molecular Medicine. 1・4. 671-675 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Fumihiro Mawatari: "Retrovirus-mediated gene therapy for hepatocellular cacrinoma:Selective and enhanced suicide gene expression regulated by human α-fetoprotein enhancer directly linked to its promoter" Cancer Gene therapy. 5・5. 301-306 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hiroki Ishikawa: "Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma" Gene therapy. (in press). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Daisaku Hida: "Suppression of a albumin and α-fetoprotein gene expression by butyrolactone I,a selective inhibitor of cdk family,in HuH-7 human hepatoma cells" Anticancer Research. (in press). (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mawatari F,et al: "Retrovirus-mediated gene therapy for hepatocellular carcinoma : Selective and enhanced suicide gene expression regulated human α-fetoprotein enhancer directly linked to its promoter." Cancer Gene Therapy. (in press). (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] Ueki T,et al: "Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice." Internationl Journal of Molecular Medicine. (in press). (1998)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi